Quarterly report pursuant to Section 13 or 15(d)

Accounting Policies - Additional Information (Detail)

v3.21.2
Accounting Policies - Additional Information (Detail) - USD ($)
$ in Millions
9 Months Ended
Aug. 01, 2021
Sep. 30, 2021
NIDA    
Accounting Policies [Line Items]    
Grant received $ 0.3  
NIH Grant    
Accounting Policies [Line Items]    
Reduction in R&D expense   $ 0.2
Grant receivable   $ 0.2